Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis

author
created [InstanceEdit:9696165] Jassal, Bijay, 2020-07-20
dbId 9696216
displayName Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis
journal Clin Ther
pages 2031-48
pubMedIdentifier 18035202
schemaClass LiteratureReference
title Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis
url http://www.ncbi.nlm.nih.gov/pubmed/18035202
volume 29
year 2007
Cite Us!